地面机器人训练对脊髓损伤者步行及继发健康问题的影响:系统综述
该系统综述遵循PRISMA指南,检索MEDLINE、EMBASE、SCOPUS、Web of Science和Cochrane library,纳入41项RCT和非RCT研究,评估商用下肢外骨骼对脊髓损伤个体的步行及14个健康领域的效果。多数显著阳性效果见于步行领域,Ekso、ReWalk、HAL和Indego设备有报告,未报告负面效应,但因研究质量、结局指标和方案异质性大,无法得出普适结论。
要点
- Ekso设备在几乎所有领域报告显著训练效果,Rex设备则未显示。
- 步行是研究最多的领域,也是多数显著阳性效果所在领域。
- 感觉功能和膀胱功能领域无任何外骨骼研究达到显著性。
核心结论
- 外骨骼训练随时间推移显示出显著改善,但其效果是否优于常规治疗或其他治疗仍大多未知。
- 由于缺乏高质量研究、结局指标和方案异质性大以及SCI流行病学/神经学特征差异,无法对外骨骼使用效果得出普适结论。
- 未报告外骨骼训练导致的负面效应,但外骨骼训练的利弊正开始被界定。
研究设计与样本
- 遵循PRISMA指南的系统综述,检索MEDLINE、EMBASE、SCOPUS、Web of Science和Cochrane library数据库。
- 纳入基于外骨骼干预脊髓损伤个体的随机临床试验(RCT)和非RCT研究。
- 筛选1296项研究,最终41项符合纳入标准。
主要发现
- Ekso设备是讨论最多的设备,其次是ReWalk、Indego、HAL和Rex设备。
- 共考虑14个不同领域,结局指标异质性大;研究最多的领域是步行,其次是心肺/代谢反应、痉挛、平衡、生活质量、人机交互、机器人数据、肠道功能、力量、日常生活活动、神经生理学、感觉功能、膀胱功能和身体成分/骨密度。
- 步行领域对Ekso、ReWalk、HAL和Indego设备报告了多数显著阳性效果。
- Ekso研究在几乎所有领域报告了显著训练效果,而Rex设备则未如此。
- 没有任何关于感觉功能或膀胱功能的外骨骼研究达到显著性。
关键数值与推荐
- Ekso研究在几乎所有领域报告显著效果,Rex设备未报告显著效果。
- 感觉功能和膀胱功能领域无任何外骨骼研究达到显著性。
- 未报告外骨骼训练导致的负面效应。
临床怎么用
- 临床医生可参考外骨骼训练在步行领域的显著改善证据,但需注意设备间差异(如Ekso与Rex的效果差异)。
- 由于缺乏高质量RCT和方案异质性,选择外骨骼训练时应结合个体情况并关注不良反应事件。
- 需要高质量RCT来更好界定当前可用外骨骼的利弊,以帮助临床医生为脊髓损伤个体选择适当训练。
局限性
- 缺乏高质量研究,如Downs and Black工具所指出。
- 结局指标、训练方案和SCI流行病学/神经学特征存在异质性。
- 无法就外骨骼使用效果得出普适结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Overground powered lower limb exoskeletons (EXOs) have proven to be valid devices in gait rehabilitation in individuals with spinal cord injury (SCI). Although several articles have reported the effects of EXOs in these individuals, the few reviews available focused on specific domains, mainly walking. The aim of this systematic review is to provide a general overview of the effects of commercial EXOs (i.e. not EXOs used in military and industry applications) for medical purposes in individuals with SCI. This systematic review was conducted following the PRISMA guidelines and it referred to MED-LINE, EMBASE, SCOPUS, Web of Science and Cochrane library databases. The studies included were Randomized Clinical Trials (RCTs) and non-RCT based on EXOs intervention on individuals with SCI. Out of 1296 studies screened, 41 met inclusion criteria. Among all the EXO studies, the Ekso device was the most discussed, followed by ReWalk, Indego, HAL and Rex devices. Since 14 different domains were considered, the outcome measures were heterogeneous. The most investigated domain was walking, followed by cardiorespiratory/metabolic responses, spasticity, balance, quality of life, human-robot interaction, robot data, bowel functionality, strength, daily living activity, neurophysiology, sensory function, bladder functionality and body composition/bone density domains. There were no reports of negative effects due to EXOs trainings and most of the significant positive effects were noted in the walking domain for Ekso, ReWalk, HAL and Indego devices. Ekso studies reported significant effects due to training in almost all domains, while this was not the case with the Rex device. Not a single study carried out on sensory functions or bladder functionality reached significance for any EXO. It is not possible to draw general conclusions about the effects of EXOs usage due to the lack of high-quality studies as addressed by the Downs and Black tool, the heterogeneity of the outcome measures, of the protocols and of the SCI epidemiological/neurological features. However, the strengths and weaknesses of EXOs are starting to be defined, even considering the different types of adverse events that EXO training brought about. EXO training showed to bring significant improvements over time, but whether its effectiveness is greater or less than conventional therapy or other treatments is still mostly unknown. High-quality RCTs are necessary to better define the pros and cons of the EXOs available today. Studies of this kind could help clinicians to better choose the appropriate training for individuals with SCI.
引用
- Tamburella F, Lorusso M, Tramontano M, et al. Overground robotic training effects on walking and secondary health conditions in individuals with spinal cord injury: systematic review. J Neuroeng Rehabil. 2022. PMID: 35292044. doi:10.1186/s12984-022-01003-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。